CD28 co-stimulation in T-cell homeostasis: a recent perspective

Area of Science:

• Immunology
• Cellular Biology

Background:

• T-cells are central to adaptive immunity, requiring antigen recognition and co-stimulation for activation.
• CD28 provides essential co-stimulatory signals through binding to CD80, CD86, or ICOSL on antigen-presenting cells.
• Cytotoxic T-lymphocyte antigen-4 (CTLA-4) regulates T-cell activation, with distinct expression patterns on regulatory T (Treg) cells and conventional T-cells.

Purpose of the Study:

• To review recent advances in understanding CD28-mediated co-stimulation.
• To explore the impact of CD28 signaling on gene regulation and T-cell subsets.
• To summarize therapeutic applications of T-cell co-stimulation, including past challenges and future prospects.

Main Methods:

• Literature review of molecular events in T-cell co-stimulation.
• Analysis of CD28's role in regulatory T cells versus conventional T-cells.
• Discussion of clinical trials and therapeutic strategies related to T-cell co-stimulation.

Main Results:

• CD28 signaling is vital for T-cell activation, gene regulation, and Treg cell homeostasis.
• Differential expression and function of CTLA-4 on Treg cells and conventional T-cells are highlighted.
• The therapeutic potential of modulating T-cell co-stimulation is significant, with ongoing clinical development.

Conclusions:

• CD28 co-stimulation is a critical regulator of T-cell responses and immune homeostasis.
• Targeting T-cell co-stimulation pathways offers promising therapeutic avenues for immune-related diseases.
• Despite past setbacks, like the TGN1412 trial, research continues to refine T-cell activation therapies.